Inclusion Criteria:
  1. Postmenopausal women
  2. Men >50-year-old
  3. After Denosumab treatment â‰¥ 2 years due to osteoporosis
Exclusion Criteria:
  1. secondary osteoporosis
  2. metabolic bone disease
  3. cancer history
  4. continuous steroid therapy
  5. hormone replacement therapy
  6. ever used any other kind of anti-resorptive treatment
6.estimated Glomerular filtration rate< 35 mL/min 7.allergy to Zoledronic acid
8.hypocalcaemia 9.any contraindications to use Zoledronic acid